Therefore, GLP-1R agonists, such as liraglutide and dulaglutide, have shown therapeutic potential in PCOS by reducing hyperandrogenemia, improving insulin sensitivity, and promoting weight loss [222,223,224,225,226,227,228,229]. This evidence concerns the gene GLP1R and polycystic ovary syndrome.